We are live on
!
Find out more
BCPEM
Bain Capital Public Equity Management Portfolio holdings
AUM
$1.05B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+6.59%
1 Year Est. Return
+25.71%
3 Year Est. Return
+127.65%
5 Year Est. Return
+213.44%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
-$209M
(-13%)
Cap. Flow
-$266M
Cap. Flow
% of AUM
-19.34%
Top 10 Holdings %
Top 10 Hldgs %
54.14%
Holding
112
New
50
Increased
12
Reduced
17
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$37.8M |
| 2 |
Fortive
FTV
|
+$30M |
| 3 |
Casey's General Stores
CASY
|
+$22.3M |
| 4 |
New York Times
NYT
|
+$22.2M |
| 5 |
RTN
Raytheon Company
RTN
|
+$21.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Puma Biotechnology
PBYI
|
+$73.6M |
| 2 |
Johnson Controls International
JCI
|
+$72.3M |
| 3 |
Jack in the Box
JACK
|
+$67.5M |
| 4 |
AABA
Altaba Inc
AABA
|
+$55M |
| 5 |
Norfolk Southern
NSC
|
+$51.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.12% |
| 2 | Industrials | 13.16% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Healthcare | 10.25% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIVV
76
PUT
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $353K | 0.03% |
+3,000
| New | +$164K |
|
77
CALL
Biogen
BIIB
$30.7B
| $210K | 0.02% |
+1,750
| New | +$561K |
|
78
PUT
Aon
AON
$76B
| $208K | 0.02% |
+1,000
| New | +$142K |
|
79
CALL
Ball Corp
BALL
$16.8B
| $194K | 0.01% |
+4,300
| New | +$174K |
|
|
SGEN
80
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $70K | 0.01% |
+5,000
| New | +$292K |
|
|
BIVV
81
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $15K | ﹤0.01% |
+2,000
| New | +$109K |
|
82
CALL
GE Aerospace
GE
$384B
| $5K | ﹤0.01% |
2,087
-7,414
| -78% | -$708K |
|
83
Advance Auto Parts
AAP
$3.49B
| – | – |
-107,187
| Closed | -$10.6M |
|
84
Amgen
AMGN
$222B
| – | – |
-141,960
| Closed | -$26.5M |
|
85
Avis
CAR
$5.02B
| – | – |
-319,219
| Closed | -$12.1M |
|
86
Crane NXT
CXT
$3.07B
| – | – |
-580,055
| Closed | -$16.1M |
|
87
Dollar General
DG
$27.9B
| – | – |
-282,331
| Closed | -$22.9M |
|
88
Dollar Tree
DLTR
$25.2B
| – | – |
-275,018
| Closed | -$23.9M |
|
|
89
PUT
GE Aerospace
GE
$384B
| – | – |
-5,217
| Closed | -$1.92M |
|
|
LKFT
90
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| – | – |
-42,026
| Closed | -$4.28M |
|
91
iShares US Real Estate ETF
IYR
$4.65B
| – | – |
-169,183
| Closed | -$13.5M |
|
|
92
CALL
Jack in the Box
JACK
$335M
| – | – |
-2,500
| Closed | -$2.39M |
|
|
93
Jack in the Box
JACK
$335M
| – | – |
-662,196
| Closed | -$67.5M |
|
94
KeyCorp
KEY
$24.4B
| – | – |
-987,404
| Closed | -$18.6M |
|
95
PUT
Eli Lilly
LLY
$1.06T
| – | – |
-2,000
| Closed | -$49K |
|
96
Merck
MRK
$318B
| – | – |
-140,524
| Closed | -$8.59M |
|
97
CALL
Nektar Therapeutics
NKTR
$2.58B
| – | – |
-200
| Closed | -$1.16M |
|
|
98
Norfolk Southern
NSC
$75.1B
| – | – |
-390,224
| Closed | -$51.6M |
|
99
Novartis
NVS
$297B
| – | – |
-370,261
| Closed | -$28.5M |
|
|
100
Puma Biotechnology
PBYI
$454M
| – | – |
-657,876
| Closed | -$73.6M |
|
Similar funds
WF
DCM
AB
MFBTD
IAS
SA
TL
ACM
Bain Capital Public Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Bain Capital Public Equity Management held 112 positions worth $1.38B, down 13% from $1.58B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Bain Capital Public Equity Management withdrew a net $266M in Q4 2017, closing 30 positions and reducing 17 holdings. Its most notable exit was Puma Biotechnology, an estimated $73.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 38% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Bain Capital Public Equity Management opened a new position in Comcast worth $40.2M.
- Bain Capital Public Equity Management's largest Q4 2017 buy was Comcast: 1,004,967 shares worth $40.2M.
- Bain Capital Public Equity Management added most to AutoZone in Q4 2017, an estimated $20.6M increase.
- Bain Capital Public Equity Management's biggest Q4 2017 reduction was Johnson Controls International, cutting an estimated $72.3M.
- Bain Capital Public Equity Management fully exited Puma Biotechnology in Q4 2017, selling an estimated $73.6M.
- Bain Capital Public Equity Management's ten largest holdings make up 54% of its $1.38B portfolio in Q4 2017.
- Bain Capital Public Equity Management opened 50 new positions and closed 30 in Q4 2017.
- Bain Capital Public Equity Management's portfolio value fell 13% quarter-over-quarter to $1.38B.
Based on Bain Capital Public Equity Management's 13F filing for Q4 2017, filed 14 Feb 2018.